Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 11/20 | 0.60 |
| ▸ | CA1 | P00915 | 11/20 | 0.60 |
| ▸ | CA2 | P00918 | 11/20 | 0.60 |
| ▸ | CA9 | Q16790 | 11/20 | 0.60 |
| ▸ | CA4 | P22748 | 6/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12383367 | 0.88 | CA1 (0.53) | CA12CA1CA2CA9CA4 | |
| SCHEMBL1233465 | 0.82 | CA12 (0.55) | CA12CA1CA2CA9CA4 | |
| SCHEMBL22898437 | 0.82 | CA1 (0.53) | CA12CA1CA2CA9CA4 | |
| SCHEMBL20607992 | 0.81 | CA1 (0.54) | CA12CA1CA2CA9CA4 | |
| SCHEMBL20607758 | 0.81 | CA1 (0.60) | CA12CA1CA2CA9CA4 | |
| SCHEMBL1232043 | 0.79 | CA12 (0.54) | CA12CA1CA2CA9CA4 | |
| SCHEMBL12383669 | 0.79 | CA1 (0.55) | CA12CA1CA2CA9CA4 | |
| SCHEMBL22847886 | 0.79 | CA1 (0.57) | CA12CA1CA2CA9CA4 | |
| SCHEMBL12383636 | 0.79 | CA1 (0.57) | CA12CA1CA2CA9CA4 | |
| SCHEMBL12475507 | 0.79 | ROCK2 (0.64) | CA12CA1CA2CA9CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110207701-A1 | BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS | ANACOR PHARMACEUTICALS, INC. (US) | 2011-08-25 | — | — | US | disclosed |
| US-20110207701-A1 | BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS | ANACOR PHARMACEUTICALS, INC. (US) | 2011-08-25 | — | — | US | disclosed |
| US-20110207701-A1 | BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS | ANACOR PHARMACEUTICALS, INC. (US) | 2011-08-25 | — | — | US | disclosed |
| WO-2011022337-A1 | BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS | ANACOR PHARMACEUTICALS, INC. (US) | 2011-02-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207701-A1 | BORON-CONTAINING SMALL MOLECULES AS ANTIPROTOZOAL AGENTS | BTD, BAD, BRI3BP | CA12 1698/4885CA1 3017/4885CA2 321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.